Docusate Sodium
- Product NDC
- 0615-0585
- 11-digit product format
- 006150585
- Labeler code
- 0615
- Product ID
- 0615-0585_058f0cf7-469c-4aa0-a95f-4f53de559d45
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- DOCUSATE SODIUM
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- part334
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2010-04-23
- Marketing end
- 0000-00-00
- Substance
- DOCUSATE SODIUM
- Active strength
- 100 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-0585-05 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-30 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-31 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-39 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |
| 0615-0585-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ea34-f424-e053-dadaa90a57ce | 7cdecfb2-e09a-4b48-b9d6-00045518825e |